QA: NeuroBo Pharmaceuticals Inc. in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001638287_2020_NeuroBo_Pharmaceuticals_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Assets', 'missing_ratio': 0.001661589587371919, 'aggregate_val': 14468000, 'exp_sum': 14444000, 'exp_to_value': {'AssetsCurrent': 14118000, 'IntangibleAssetsNetIncludingGoodwill': 0, 'PropertyPlantAndEquipmentNet': 200000, 'remainder_Assets': 126000}}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001638287')"}
info Ambiguous roles for statement input.sec.calculation_linkbase.expand_agg {'statement': 'operations', 'valid_roles': {'00200 - Statement - Consolidated Statements of Operations and Comprehensive Loss': 10, '00205 - Statement - Condensed Statements of Comprehensive Loss (Calc 2)': 2}}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001638287, NeuroBo Pharmaceuticals Inc.

  xvar xval
0 AssetsCurrent 14,118,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 200,000
3 remainder_Assets 150,000
4 LiabilitiesCurrent 2,082,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 94,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 2,701,000
9 ResearchAndDevelopmentExpense 17,475,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -1,136,000
13 remainder_ComprehensiveNetIncome 10,000
  yvar yval
0 Assets 14,468,000
1 Liabilities 2,176,000
2 Expenses 20,176,000
3 Revenues 0
4 StockholdersEquity 12,292,000
5 NetIncome -21,312,000
6 ComprehensiveNetIncome -21,307,000
7 BaseVar 18,983,000
8 EconomicCapitalRatio -0.0198

Edgar->Model Mapping

Feature Distribution

Change over Time